Bulk Pharmaceutical API Sources for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

Bulk Pharmaceutical API Sources for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-016-638-321
AKos Consulting & Solutions		AKOS025311215
Alfa Chemistry		74356-00-6
MuseChem		I005923

Bulk Active Pharmaceutical Ingredient (API) Sources for Cefotetan and Dextrose in Duplex Containers

Last updated: July 27, 2025

---

Introduction

In pharmaceutical manufacturing, especially in sterile formulations like intravenous (IV) medications, sourcing high-quality active pharmaceutical ingredients (APIs) is crucial for ensuring product safety, efficacy, and regulatory compliance. Cefotetan, a second-generation cephalosporin antibiotic, combined with dextrose, forms a common dual-compartment IV solution, often packaged in duplex containers to maintain sterility and stability. This article provides a comprehensive analysis of the primary global sources for bulk APIs of Cefotetan and Dextrose suitable for duplex container formulations, emphasizing quality standards, supply reliability, and regulatory considerations.

---

Overview of Cefotetan and Dextrose as Pharmaceutical APIs

Cefotetan
Cefotetan is a broad-spectrum cephalosporin antibiotic used to treat various bacterial infections, including respiratory and urinary tract infections. Its API must meet stringent purity criteria, including low levels of impurities, endotoxins, and residual solvents, due to its parenteral route of administration.

Dextrose (D-Glucose)
Dextrose, a form of glucose used as a carbohydrate source in IV infusions, must be pharmaceutically pure, free from microbial contamination, and stable under storage conditions. Its API form originates either from natural fermentation or chemical synthesis, with strict quality standards.

---

Global API Manufacturers for Cefotetan

Major Sources and Leading Suppliers

1. Hospira (Pfizer)

   • Overview: Hospira, now part of Pfizer, has historically been a key supplier of cefotetan API, with manufacturing facilities adhering to cGMP standards.
   • Supply Scope: Supplies bulk API directly to pharmaceutical companies globally, with facilities in the U.S. and Europe.
   • Regulatory Status: Approved by FDA, EMA, and other major regulatory bodies; API manufactured under strict quality protocols.

2. Biochem Pharmaceutical Industries

   • Location: India
   • Capabilities: Produces cefotetan API compliant with international standards, including WHO GMP, USFDA, and EMA certifications.
   • Market Position: Known for flexible supply options and competitive pricing.

3. Jiangsu Taknong Pharmaceuticals

   • Location: China
   • Strengths: Established biopharmaceutical manufacturer with growing global export footprint.
   • Quality Assurance: Certified by GMP, with ISO 9001 standards in place for API production.

4. Qingdao Eastchem Co. Ltd.

   • Location: China
   • Offerings: Supplies cefotetan API with rigorous quality control, targeting global markets with reliable supply chains.

---

API Sources for Dextrose (D-Glucose)

Leading Manufacturers of Pharmaceutical Dextrose

1. Wacker Chemie AG

   • Overview: A German-based global leader in manufacturing pharmaceutical-grade dextrose, including D-Glucose monohydrate.
   • Quality Standards: GMP-certified facilities, ensuring compliance with USP, EP, and JP standards.

2. Roquette Frères

   • Location: France
   • Expertise: International supplier of high-grade dextrose monohydrate for parenteral use, with extensive R&D capabilities and quality control.
   • Regulatory Compliance: Meets FDA, EMA, and other key regulatory standards.

3. Harbin Pharmaceutical Group Co., Ltd.

   • Location: China
   • Market Reach: Supplies bulk pharmaceutical-grade dextrose for injectables, with GMP licenses granted by Chinese authorities and approved export capabilities.

4. Millennium TheraMix

   • Location: India
   • Supply Lines: Offers pharmaceutical-grade dextrose, with an emphasis on consistent batch quality and regulatory approvals for global markets.

---

Quality and Regulatory Considerations

API Quality Standards
Both cefotetan and dextrose APIs must comply with pharmacopeial monographs like USP, EP, or JP, including tests for identity, purity, residual solvents, endotoxins, and microbial contamination. For parenteral use, endotoxin testing (LAL test) and sterility assurance are imperative.

Certifications and Good Manufacturing Practice (GMP)
Manufacturers must hold GMP certifications from relevant authorities—FDA, EMA, or equivalent—to ensure consistent quality. Many suppliers also pursue ISO 9001, ISO 13485, and other international quality standards to bolster credibility.

Supply Chain Reliability
Given the critical nature of IV formulations, manufacturers prefer suppliers with proven supply stability, compliance track records, and capacity to meet global demand, especially for large-volume projects.

---

Packaging in Duplex Containers

Advantages of Duplex Containers
Duplex containers—comprising a primary sterile container inside an outer package—provide enhanced barrier properties, preserving stability and sterility for sensitive APIs like cefotetan and dextrose. Suppliers often coordinate closely with packaging vendors to ensure API compatibility with duplex container materials such as rubber stoppers and medical-grade plastics.

API Compatibility and Handling
APIs must be suitable for aqueous sterile solutions, with minimal leachables or extractables from container materials. Suppliers must provide certificates ensuring API stability within duplex containers throughout the shelf life.

---

Emerging Trends and Future Outlook

• Local Manufacturing Growth: India and China continue expanding their API manufacturing capabilities, aiming for self-sufficiency in critical APIs like cefotetan and dextrose.
• Regulatory Harmonization: Increasing alignment of manufacturing standards globally enhances supply chain robustness.
• Sustainable Production: Eco-friendly manufacturing practices, including waste reduction and green chemistry, influence selection criteria for pharmaceutical companies.
• Supply Chain Diversification: To mitigate geopolitical risks, pharmaceutical firms seek multiple reliable suppliers across regions.

---

Key Considerations for Procurement

1. Regulatory Status: Ensure supplier certifications align with target markets’ requirements.
2. Quality Assurance: Verify batch-to-batch consistency, stability data, and compliance documentation.
3. Supply Chain Security: Opt for suppliers with proven logistics capabilities and contingency plans.
4. Cost Considerations: Balance between cost, quality, and supply reliability, considering the total cost of ownership.
5. Technical Support and Documentation: Supplier transparency regarding API specifications, stability profiles, and compatibility with duplex containers.

---

Key Takeaways

• Reliable sourcing of cefotetan and dextrose APIs hinges on selecting suppliers with established GMP certifications, proven quality standards, and comprehensive regulatory compliance.
• Major suppliers include global leaders like Pfizer’s Hospira, Wacker Chemie, and Roquette, alongside competent regional manufacturers in India, China, and Europe.
• Ensuring API compatibility with duplex container packaging requires detailed stability data, certificates of analysis, and thorough understanding of material-API interactions.
• The increasing emphasis on quality, sustainability, and supply security is shaping procurement strategies across the pharmaceutical industry.
• Diversification of API sources is critical to mitigate risks and meet global demand effectively.

---

FAQs

Q1: What are the primary regulatory standards to consider when sourcing cefotetan and dextrose APIs?
A1: The key standards include USP, EP, and JP pharmacopeias, with additional requirements for GMP certification from authorities such as FDA and EMA.

Q2: How do suppliers ensure the quality of APIs intended for duplex container formulations?
A2: Suppliers provide Certificates of Analysis (CoA), stability data, endotoxin and microbial testing results, and compliance documentation aligned with pharmacopeial standards.

Q3: Why is supply chain diversification important for APIs like cefotetan and dextrose?
A3: Diversification reduces dependency on single suppliers, mitigating risks from geopolitical disruptions, regulatory changes, and manufacturing issues.

Q4: Are regional manufacturers capable of supplying APIs compliant with international standards?
A4: Yes, many regional manufacturers in India and China now operate under GMP and hold certifications (e.g., ISO 9001), ensuring compliance with global regulatory requirements.

Q5: How do manufacturing processes impact the choice of APIs for duplex containers?
A5: Processes affecting API purity, residual solvent levels, and impurity profiles influence compatibility with packaging materials and stability within duplex containers.

---

References

1. U.S. Pharmacopeia (USP).
   
2. European Pharmacopoeia (EP).
   
3. World Health Organization (WHO). Manufacturing Standards for APIs.
   
4. FDA and EMA approved API manufacturers.
   
5. Industry reports on global API manufacturing trends and certifications.

---

This comprehensive guide aims to assist pharmaceutical professionals in selecting optimal API sources for cefotetan and dextrose, ensuring safety, quality, and supply stability for duplex container formulations.